,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,31274,3,4,,103288359,19347,Unspecified,,,,,Methylthio adduct formation rate expressed as nanomoles of methylthio adduct formed per mg of protein per 30 min,Other,7108899.0,
1,31275,3,4,,103288359,19347,Unspecified,,,,,AHAT catalyzed transacylation was determined; Rate expressed as nanomoles of AAB acylated per mg of protein per 5 min,Other,7108899.0,
2,167925,3,3,,103288359,19347,Unspecified,,,,,Carcinogenic activity on all sites after intraperitoneal administration,Other,7265110.0,
3,167936,3,3,,103288359,19347,Unspecified,,,,,Carcinogenic activity on breast after intraperitoneal administration,Other,7265110.0,
4,167947,3,3,,103288359,19347,Unspecified,,,,,Carcinogenic activity on ear duct after intraperitoneal administration,Other,7265110.0,
5,168083,3,3,,103288359,19347,Unspecified,,,,,Carcinogenic activity on liver after intraperitoneal administration,Other,7265110.0,
6,168108,3,3,,103288359,19347,Unspecified,,,,,Compound was tested for carcinogenic activity on other sites after intraperitoneal administration of the compound; + denotes carcinogenic activity.,Other,7265110.0,
7,1259407,1,1,,363900669,19347,Active,,,,,CCRIS mutagenicity studies,Other,,
